Skip to content
ContentLora

    Tip: press / anywhere to search.

    Analysis

    The Mediterranean diet: what trials and cohort studies show

    The Mediterranean diet has been tested in randomised trials: the PREDIMED trial found fewer major cardiovascular events in high-risk Spanish adults than a reduced-fat control diet, and the CORDIOPREV trial found fewer major cardiovascular events in heart patients than a low-fat diet.[1][2] But PREDIMED had to be withdrawn and reanalysed over randomisation problems, and a 2019 Cochrane review still judged the effects on clinical outcomes uncertain, with low- to moderate-quality evidence.[3][4] A large cohort study linked the diet to lower death rates, but observational studies show association, not cause, and a 2023 trial of a related diet found no effect on cognition.[5][6]

    Editor reviewedStrict sourcingUpdated Analysis14 claims · 100% primaryNutrition and fitness, Health and medicine
    Show:

    Evidence on the Mediterranean diet comes from both randomised trials and long-running cohort studies.[7][1] This page separates what the trials show, where the evidence is weaker, and how the competing readings differ.

    This page is general information, not medical advice. Talk to a clinician before making major changes to how you eat, especially if you have a heart condition or diabetes.

    Where the idea came from

    The Cochrane review traces the idea to the 1960s Seven Countries study, which found lower coronary heart disease death rates in Mediterranean populations, probably reflecting different diets. Later observational studies supported a benefit, while trial evidence was more limited.[7] Cochrane defines the diet by two core features, a high ratio of monounsaturated to saturated fat (such as olive oil or tree nuts) and plenty of fruit, vegetables and legumes, plus typical extras such as whole grains, more fish, less meat and moderate dairy.[8]

    What the randomised trials show

    PREDIMED assigned 7,447 Spanish adults aged 55 to 80 at high cardiovascular risk to a Mediterranean diet with extra-virgin olive oil, one with mixed nuts, or a reduced-fat control diet.[1] After a median 4.8 years, major cardiovascular events occurred in 3.8%, 3.4% and 4.4% respectively, hazard ratios of 0.69 and 0.72 versus control.[1] The investigators withdrew their original 2013 report after finding that some household members were enrolled without randomisation and that one of 11 sites assigned some participants non-randomly; results were similar after excluding 1,588 affected participants.[3]

    For people who already have heart disease, the Lyon Diet Heart Study randomised 605 heart attack survivors and reported 14 versus 44 cardiac deaths and non-fatal heart attacks over a mean 46 months, though Cochrane rated that evidence low quality.[9] The single-centre CORDIOPREV trial in Córdoba, Spain, randomised 1,002 coronary heart disease patients to a Mediterranean or low-fat diet for 7 years. Major cardiovascular events occurred in 87 versus 111 patients, with adjusted hazard ratios of about 0.72 to 0.75.[2] Most participants were men, the benefit was seen in men, and no difference was found in the 175 women; participants knew their diet, and funders included olive oil foundations.[10]

    How strong the evidence is

    The 2019 Cochrane review included 30 randomised trials with 12,461 participants. It concluded there is still some uncertainty about the diet’s effects on clinical outcomes and risk factors, and little evidence for secondary prevention.[4] It rated as low quality the evidence that the PREDIMED intervention had little or no effect on cardiovascular or total deaths, and as moderate quality that it reduced strokes, from 24 to 14 per 1,000.[11] Against minimal or no intervention, it found moderate-quality evidence of about 3 mmHg lower systolic and 2 mmHg lower diastolic blood pressure.[12]

    Cohort studies add scale but not proof of cause. In the Women’s Health Study, 25,315 initially healthy women were followed for a mean of 24.7 years, and higher adherence was associated with 23% lower all-cause mortality. The authors said cardiometabolic factors partly explained the link.[5] For the brain, a 2023 trial of the MIND diet, a Mediterranean-DASH hybrid, in 604 older adults with a family history of dementia found no difference in cognition or brain MRI over 3 years compared with a control diet with mild calorie restriction.[6][13]

    The trials and the cohorts point the same way on the heart, but each has a weakness. The trials are few and mostly from Spain, participants in CORDIOPREV knew which diet they were on, and the two largest compared the diet with low-fat advice rather than with no dietary advice. The cohorts are large and long, but people who eat this way may differ in income, exercise and other habits. One reading is that the trial evidence for fewer cardiovascular events, especially strokes, in high-risk Spanish groups is fairly consistent, even though Cochrane still rates the overall effects as uncertain, while claims about longevity in general and dementia are much less settled.

    Competing views

    The views panel sets out three readings. Supporters point to two Spanish trials that each found about 25% to 31% lower rates of major events than a reduced-fat or low-fat comparison diet, and to PREDIMED’s result holding up after reanalysis.[3][2] More cautious readers point to the Cochrane review’s quality ratings and its finding of little or no effect on deaths in PREDIMED.[11][4] Others note that benefits beyond the heart rest mainly on cohort data, and that the MIND trial was null.[5][6] The Keto-Med crossover trial, which compared a ketogenic diet with a Mediterranean-style diet in people with prediabetes or type 2 diabetes, is covered in the keto and low-carb analysis.[14]

    What may come next

    Labelled forecast: in 2019 the Cochrane authors listed seven ongoing trials, and their results are the most likely way the certainty ratings change.[4] Trials outside Spain, and more trials in women, would do most to settle whether the heart benefits generalise. Brain-health claims will probably keep resting on cohort data, given the null MIND result. This is our assessment, with substantial uncertainty.

    Competing views

    Among the best-supported diets

    Two Spanish randomised trials, one in primary and one in secondary prevention, found about 25% to 31% lower rates of major cardiovascular events than a reduced-fat or low-fat comparison diet (hazard ratios 0.69 to 0.75), and the PREDIMED result held up after its reanalysis.[1][3][2]

    Promising but less certain than it looks

    The Cochrane review rated most of the evidence low or moderate quality, found little or no effect on deaths in PREDIMED, and found little secondary-prevention evidence. The key trials come from one country, and CORDIOPREV found no difference in women.[11][4][10]

    Benefits beyond the heart are unproven

    Cohort studies link the diet to lower mortality, but they show association, not cause, and a 3-year trial of the related MIND diet did not improve cognition compared with a control diet.[5][6]

    Next in the crash course

    More in Nutrition & fitness

    Questions readers ask

    What counts as a Mediterranean diet?

    The 2019 Cochrane review required two features, a high ratio of monounsaturated to saturated fat (such as olive oil as the main cooking fat, or tree nuts) and plenty of plant foods including fruit, vegetables and legumes. Other typical features include whole grains, more fish, less meat and moderate dairy.[8]

    What did the PREDIMED trial find?

    Among 7,447 Spanish adults aged 55 to 80 at high cardiovascular risk, major cardiovascular events occurred in 3.8% on a Mediterranean diet with extra-virgin olive oil, 3.4% with nuts and 4.4% on a reduced-fat control diet over a median 4.8 years.[1]

    Why was PREDIMED retracted?

    The investigators found protocol deviations, including household members enrolled without randomisation and non-random assignment at one of 11 sites. They withdrew the 2013 paper and published a 2018 reanalysis; results were similar after excluding 1,588 affected participants.[3]

    Does the Mediterranean diet help people who already have heart disease?

    In the CORDIOPREV trial of 1,002 coronary heart disease patients in Spain, major cardiovascular events over 7 years occurred in 87 on a Mediterranean diet and 111 on a low-fat diet. The benefit was seen in men; no difference was found in the 175 women.[2][10]

    Does the Mediterranean diet prevent dementia?

    That is not established. In a 2023 trial of 604 older adults with a family history of dementia, the MIND diet, a Mediterranean-DASH hybrid, did not change cognition or brain MRI measures over 3 years compared with a control diet with mild calorie restriction.[6][13]

    Sources

    · 14 claims from 6 publishers

    Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.

    1. [1]

      The PREDIMED trial assigned 7,447 Spanish adults aged 55 to 80 at high cardiovascular risk to a Mediterranean diet with extra-virgin olive oil, one with mixed nuts, or a reduced-fat control diet; after a median 4.8 years, major cardiovascular events occurred in 3.8%, 3.4% and 4.4% respectively (hazard ratios 0.69 and 0.72 versus control). confirmedas of 2026-11-14

    2. [2]

      In the single-centre CORDIOPREV trial in Córdoba, Spain, 1,002 patients with coronary heart disease were randomised to a Mediterranean or low-fat diet for 7 years; major cardiovascular events occurred in 87 versus 111 patients, with adjusted hazard ratios of about 0.72 to 0.75 favouring the Mediterranean diet. confirmedas of 2026-11-14

    3. [3]

      PREDIMED's investigators withdrew their 2013 report after finding protocol deviations, including enrolling household members without randomisation and non-random assignment at one of 11 sites, and republished revised estimates in 2018; results were similar after excluding 1,588 affected participants. confirmedas of 2026-11-14

    4. [4]

      The 2019 Cochrane review of 30 randomised trials (12,461 participants), which also identified seven ongoing trials, concluded there is still some uncertainty about the effects of a Mediterranean-style diet on clinical outcomes and risk factors, with low- or moderate-quality evidence for modest benefits on risk factors in primary prevention and little evidence for secondary prevention. confirmedas of 2026-11-14

    5. [5]

      In a 2024 observational analysis of 25,315 initially healthy women in the Women's Health Study, followed for a mean of 24.7 years, higher Mediterranean diet adherence was associated with 23% lower all-cause mortality, an association the authors said was partly explained by cardiometabolic factors. confirmedas of 2026-11-14

    6. [6]

      In a 2023 NEJM trial of 604 cognitively unimpaired older adults with a family history of dementia, the MIND diet, which draws on Mediterranean and DASH diets, did not change cognition or brain MRI measures over 3 years compared with a control diet with mild calorie restriction. confirmedas of 2026-11-14

    7. [7]

      The Cochrane review notes that the 1960s Seven Countries study found lower coronary heart disease death rates in Mediterranean populations, probably reflecting different dietary patterns, and that later observational studies supported benefits while trial evidence was more limited. confirmedas of 2026-11-14

    8. [8]

      A 2019 Cochrane review defined a Mediterranean-style diet as having a high ratio of monounsaturated to saturated fat (such as olive oil as the main cooking fat, or tree nuts) and a high intake of plant foods including fruit, vegetables and legumes, with other typical features including whole grains, more fish, less meat and moderate dairy. confirmedas of 2026-11-14

    9. [9]

      The Lyon Diet Heart Study randomised 605 heart attack survivors to advice on a Mediterranean-type diet or usual care; it reported fewer cardiac deaths and non-fatal heart attacks (14 vs 44 events) over a mean 46 months, though Cochrane rated the evidence low quality. confirmedas of 2026-11-14

    10. [10]

      In CORDIOPREV, 82.5% of participants were men, the benefit was more evident in men, and no difference between diets was found in the 175 women; participants knew their diet group, and funders included olive oil foundations. confirmedas of 2026-11-14

    11. [11]

      The 2019 Cochrane review rated the evidence low quality that the PREDIMED intervention had little or no effect on cardiovascular or total mortality, and moderate quality that it reduced strokes (HR 0.60, from 24 to 14 per 1,000). confirmedas of 2026-11-14

    12. [12]

      For primary prevention against minimal or no intervention, the Cochrane review found moderate-quality evidence that a Mediterranean-style diet lowered systolic blood pressure by about 3 mmHg and diastolic by about 2 mmHg. confirmedas of 2026-11-14

    13. [13]

      The MIND diet tested in the 2023 trial is a hybrid of the Mediterranean and DASH diets. confirmedas of 2026-11-14

    14. [14]

      In the Keto-Med crossover trial, 40 adults with prediabetes or type 2 diabetes followed a ketogenic diet and a Mediterranean-plus diet for 12 weeks each; HbA1c did not differ between diets, the ketogenic diet lowered triglycerides more (-16% vs -5%) but raised LDL cholesterol (+10% vs -5%), and the Mediterranean-plus diet looked more sustainable at follow-up. confirmedas of 2026-11-14

    Revision history (1)
    1. Page created.

    Created Nov 14, 2026. Last reviewed by an editor on Nov 14, 2026. Next scheduled review: May 14, 2027.

    Cite this page

    "The Mediterranean diet: what trials and cohort studies show." ContentLora, updated Nov 14, 2026. https://contentlora.com/analysis/mediterranean-diet-evidence-debate

    Spotted an error? Suggest a correction or emailcorrections@contentlora.com.